These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 27433378)
1. Prolonged versus Intermittent Infusion of β-Lactams for the Treatment of Nosocomial Pneumonia: A Meta-Analysis. Lal A; Jaoude P; El-Solh AA Infect Chemother; 2016 Jun; 48(2):81-90. PubMed ID: 27433378 [TBL] [Abstract][Full Text] [Related]
2. Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials. Tamma PD; Putcha N; Suh YD; Van Arendonk KJ; Rinke ML BMC Infect Dis; 2011 Jun; 11():181. PubMed ID: 21696619 [TBL] [Abstract][Full Text] [Related]
3. Loading dose and efficacy of continuous or extended infusion of beta-lactams compared with intermittent administration in patients with critical illnesses: A subgroup meta-analysis and meta-regression analysis. Wu CC; Su YC; Wu KS; Wu TH; Yang CS J Clin Pharm Ther; 2021 Apr; 46(2):424-432. PubMed ID: 33135261 [TBL] [Abstract][Full Text] [Related]
4. Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials. Roberts JA; Abdul-Aziz MH; Davis JS; Dulhunty JM; Cotta MO; Myburgh J; Bellomo R; Lipman J Am J Respir Crit Care Med; 2016 Sep; 194(6):681-91. PubMed ID: 26974879 [TBL] [Abstract][Full Text] [Related]
5. Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis. Abdul-Aziz MH; Sulaiman H; Mat-Nor MB; Rai V; Wong KK; Hasan MS; Abd Rahman AN; Jamal JA; Wallis SC; Lipman J; Staatz CE; Roberts JA Intensive Care Med; 2016 Oct; 42(10):1535-1545. PubMed ID: 26754759 [TBL] [Abstract][Full Text] [Related]
6. Prolonged versus intermittent β-lactam antibiotics intravenous infusion strategy in sepsis or septic shock patients: a systematic review with meta-analysis and trial sequential analysis of randomized trials. Kondo Y; Ota K; Imura H; Hara N; Shime N J Intensive Care; 2020; 8():77. PubMed ID: 33042550 [TBL] [Abstract][Full Text] [Related]
7. Comparison of extended versus intermittent infusion of antipseudomonal beta-lactams for the treatment of critically ill patients with respiratory infections: A systematic review and meta-analysis. Aboulatta L; Sugita H; Wakabayashi H; Noma H; Sasaki T Int J Infect Dis; 2020 Sep; 98():41-50. PubMed ID: 32535299 [TBL] [Abstract][Full Text] [Related]
8. Continuous Infusion Versus Intermittent Bolus of Beta-Lactams in Critically Ill Patients with Respiratory Infections: A Systematic Review and Meta-analysis. Lee YR; Miller PD; Alzghari SK; Blanco DD; Hager JD; Kuntz KS Eur J Drug Metab Pharmacokinet; 2018 Apr; 43(2):155-170. PubMed ID: 29027128 [TBL] [Abstract][Full Text] [Related]
9. Prolonged administration of β-lactam antibiotics - a comprehensive review and critical appraisal. Osthoff M; Siegemund M; Balestra G; Abdul-Aziz MH; Roberts JA Swiss Med Wkly; 2016; 146():w14368. PubMed ID: 27731492 [TBL] [Abstract][Full Text] [Related]
10. Prolonged infusion versus intermittent boluses of β-lactam antibiotics for treatment of acute infections: a meta-analysis. Teo J; Liew Y; Lee W; Kwa AL Int J Antimicrob Agents; 2014 May; 43(5):403-11. PubMed ID: 24657044 [TBL] [Abstract][Full Text] [Related]
11. Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials. Vardakas KZ; Voulgaris GL; Maliaros A; Samonis G; Falagas ME Lancet Infect Dis; 2018 Jan; 18(1):108-120. PubMed ID: 29102324 [TBL] [Abstract][Full Text] [Related]
12. A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III. Lipman J; Brett SJ; De Waele JJ; Cotta MO; Davis JS; Finfer S; Glass P; Knowles S; McGuinness S; Myburgh J; Paterson DL; Peake S; Rajbhandari D; Rhodes A; Roberts JA; Shirwadkar C; Starr T; Taylor C; Billot L; Dulhunty JM Crit Care Resusc; 2019 Mar; 21(1):63-68. PubMed ID: 30857514 [TBL] [Abstract][Full Text] [Related]
13. The Pharmacodynamics of Prolonged Infusion β-Lactams for the Treatment of Pseudomonas aeruginosa Infections: A Systematic Review. Thabit AK; Hobbs ALV; Guzman OE; Shea KM Clin Ther; 2019 Nov; 41(11):2397-2415.e8. PubMed ID: 31679822 [TBL] [Abstract][Full Text] [Related]
14. Prolonged Infusion Piperacillin-Tazobactam Decreases Mortality and Improves Outcomes in Severely Ill Patients: Results of a Systematic Review and Meta-Analysis. Rhodes NJ; Liu J; O'Donnell JN; Dulhunty JM; Abdul-Aziz MH; Berko PY; Nadler B; Lipman J; Roberts JA Crit Care Med; 2018 Feb; 46(2):236-243. PubMed ID: 29116995 [TBL] [Abstract][Full Text] [Related]
15. Prolonged infusion antibiotics for suspected gram-negative infections in the ICU: a before-after study. Arnold HM; Hollands JM; Skrupky LP; Smith JR; Juang PH; Hampton NB; McCormick S; Reichley RM; Hoban A; Hoffmann J; Micek ST; Kollef MH Ann Pharmacother; 2013 Feb; 47(2):170-80. PubMed ID: 23341160 [TBL] [Abstract][Full Text] [Related]